Premium Nahrungsergänzungsmittel | artgerecht

Mast Cell Activation Syndrome (MCAS) – Symptoms & Treatment

Mast Cell Activation Syndrome (MCAS) is a chronic immune disorder in which mast cells are repeatedly and excessively activated, releasing inflammatory mediators that trigger a wide range of symptoms.

Regular tips about health Regular tips about health

Things worth knowing about "Mast Cell Activation Syndrome"

Mast Cell Activation Syndrome (MCAS) is a chronic immune disorder in which mast cells are repeatedly and excessively activated, releasing inflammatory mediators that trigger a wide range of symptoms.

What Is Mast Cell Activation Syndrome?

Mast Cell Activation Syndrome (abbreviated MCAS) is a chronic condition of the immune system in which specialized immune cells called mast cells become repeatedly and inappropriately activated. Mast cells are found in virtually every tissue in the body and play a key role in immune defense and allergic responses. In MCAS, these cells release excessive amounts of chemical messengers known as mediators -- including histamine, tryptase, and prostaglandins -- causing a wide variety of symptoms across multiple organ systems.

Causes

The exact causes of MCAS are not yet fully understood. Three main subtypes are recognized:

Primary MCAS: Caused by clonal proliferation of mast cells, as seen in mastocytosis or certain hematological disorders.
Secondary MCAS: Mast cells are activated by an underlying condition such as allergies, chronic infections, or autoimmune diseases.
Idiopathic MCAS: No identifiable cause is found; mast cells react excessively without a clear external trigger.

Common triggers for mast cell activation include stress, heat, cold, certain foods, medications, physical exertion, and infections.

Symptoms

MCAS is characterized by a remarkably diverse range of symptoms. Because mast cells are present in nearly all organs, complaints can arise throughout the entire body:

Skin: Flushing, itching, hives (urticaria), wheals
Gastrointestinal tract: Abdominal pain, nausea, vomiting, diarrhea, bloating
Respiratory system: Shortness of breath, coughing, nasal congestion or runny nose
Cardiovascular system: Rapid heartbeat (tachycardia), low blood pressure, dizziness, or fainting
Neurological symptoms: Difficulty concentrating (often called brain fog), headaches, fatigue
Muscle and joint pain

In severe cases, MCAS can trigger an anaphylactic reaction, which constitutes a medical emergency requiring immediate treatment.

Diagnosis

Diagnosing MCAS can be challenging due to its non-specific and highly variable symptoms. Diagnosis typically requires meeting three criteria:

Characteristic symptoms: Recurrent complaints affecting multiple organ systems.
Laboratory evidence: Elevated mast cell mediators in blood or urine, particularly tryptase, histamine, or its metabolites (e.g., methylhistamine in urine).
Response to therapy: Improvement of symptoms following treatment with medications that inhibit mast cells or their mediators (e.g., antihistamines).

In cases where primary mastocytosis is suspected, additional investigations such as bone marrow biopsy or specific genetic testing (e.g., KIT D816V mutation) may be performed.

Treatment

There is currently no cure for MCAS. Treatment focuses on controlling symptoms and avoiding known triggers.

Pharmacological Treatment

Antihistamines (H1 and H2 blockers): Block the effects of histamine at target receptors and form the cornerstone of MCAS management.
Mast cell stabilizers: Agents such as cromolyn sodium prevent the release of mediators from mast cells.
Leukotriene antagonists: Inhibit another class of inflammatory signaling molecules.
Corticosteroids: Used short-term during severe episodes.
Epinephrine auto-injector: Prescribed for patients at risk of anaphylaxis as an emergency intervention.

Non-Pharmacological Measures

Keeping a symptom diary to identify individual triggers
Dietary adjustments (e.g., low-histamine diet)
Stress management and consistent avoidance of known triggers

References

Valent P. et al. - Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal. International Archives of Allergy and Immunology, 2012.
Akin C. - Mast cell activation syndromes. Journal of Allergy and Clinical Immunology, 2017.
Molderings G.J. et al. - Mast cell disease: a comprehensive introduction. Leukemia and Lymphoma, 2011.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.